-
2025-521908-22-00
10
EGFR-mutated Non-small Cell Lung Cancer
-
2025-522140-40-00
4
multiple sclerosis
-
2025-523586-18-00
5
Non-Small Cell Lung Cancer
-
2024-512659-19-00
10
2025-03-31
Advanced Melanoma
-
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
-
2023-504918-29-00
5
2024-08-22
Hormone receptor positive breast cancer
-
2023-504308-27-00
5
2024-06-06
non-squamous non-small cell lung cancer
-
2022-500273-14-00
10
2023-07-17
Atherosclerotic cardiovascular disease in patients with ESKD
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2024-517606-29-00
5
2020-10-30
Central retinal artery occlusion
-
2024-513927-18-00
4
2026-02-16
Amyotrophic Lateral Sclerosis
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2023-509022-22-00
5
2025-08-21
Pancreatic ductal cancer
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2024-519797-39-00
6
2025-07-01
Sepsis
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2023-509907-34-01
5
2025-03-10
acute ischemic stroke
-
2023-509994-22-00
5
2024-11-15
cutaneous malignant melanoma
-
2024-513017-12-00
6
2024-10-24
Juvenile Idiopathic Arthritis
-
2023-508012-35-00
5
2024-10-02
Newly diagnosed NSCLC with resectable clinical Stage II, IIIA or IIIB
-
2023-510381-28-01
6
2024-09-18
Patients undergoing plastic surgical procedures with wounds that would
-
2023-506704-14-00
4
2024-09-04
Moderately to Severely Active Crohn's Disease